Bieżący suplement Archiwum Klinika Oczna |
1-2/2004
vol. 106 streszczenie artykułu:
Artykuł oryginalny
Porównanie skuteczności terapii skojarzonej 0,5% timololem i 2% dorzolamidem oraz 0,5% timololem i 2% pilokarpiną w leczeniu jaskry pierwotnej otwartego kąta i nadciśnienia ocznego
Jakub J. Kałużny
1
,
Jerzy Szaflik
2
,
Krystyna Czechowicz-Janicka
3
,
Józef Kałużny
1
,
Alicja Orzałkiewicz
1
,
Anna Zaleska-Żmijewska
2
,
Małgorzata Krajewska
3
,
Jeanette A. Stewar
4
,
Jessica N. Leech
4
,
Wiliam C. Stewar
4, 5
KLINIKA OCZNA 2004, Supl. 1-2: S241–S242
Data publikacji online: 2022/12/30
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Purpose To establish the efficacy and safety of timolol 0,5% / dorzolamide 2% fixed combination versus timolol 0,5% / pilocarpine 2% fixed combination, each given twice daily, in primary open-angle glaucoma and ocular hypertensive patients. Material and methods In this prospective, multicentred, double-masked trial, 37 patients were treated twice daily with timolol for 4 weeks. Then, they were randomized to one of the treatment medications for 6 weeks, after which they were treated with timolol again for 2 weeks before placed on the opposite treatment medication for 6 weeks. Results A total of 36 patients completed the trial. The mean baseline intraocular pressure (IOP) was 22,3± 3,7 mmHg. Following 6 weeks of treatment, the mean decrease of IOP was 18,0± 2,2 mmHg for timolol / dorzolamide combination and 17,4± 2,0 for timolol / pilocarpine combination. The mean diurnal curve IOP was 18,1± 2,2 mmHg for timolol / dorzolamide group and 16,7 ± 1,9 mmHg for timolol / pilocarpine group. These differences were statistically significant. Statistically more patients reported ocular pain and diminished vision during use of the timolol / pilocarpine combination. Conclusions This study suggest that timolol 0,5% / pilocarpine 2% fixed combination can provide at least similar efficacious reduction in IOP as timolol 0,5 % / dorzolamide 2% fixed combination in patients with primary open-angle glaucoma and ocular hypertension. |